TrianglePUBLICATIONS · 30212295
National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2018 Nov 10
- First author
- Seidman AD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Seidman AD
- type
- Author
- name
- Bordeleau L
- type
- Author
- name
- Fehrenbacher L
- type
- Author
- name
- Barlow WE
- type
- Author
- name
- Perlmutter J
- type
- Author
- name
- Rubinstein L
- type
- Author
- name
- Wedam SB
- type
- Author
- name
- Hershman DL
- type
- Author
- name
- Hayes JF
- type
- Author
- name
- Butler LP
- type
- Author
- name
- Smith ML
- type
- Author
- name
- Regan MM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Seidman AD
- type
- Author
- name
- Bordeleau L
- type
- Author
- name
- Fehrenbacher L
- type
- Author
- name
- Barlow WE
- type
- Author
- name
- Perlmutter J
- type
- Author
- name
- Rubinstein L
- type
- Author
- name
- Wedam SB
- type
- Author
- name
- Hershman DL
- type
- Author
- name
- Hayes JF
- type
- Author
- name
- Butler LP
- type
- Author
- name
- Smith ML
- type
- Author
- name
- Regan MM
- type
- Author
- bibliography ids
- nci-bib-ddfd4d83edcc84c7da3a6e99
- book metadata
- content sha256
- 19092f6449f2278835b27fdb4e1147e240fa0decfc5688fc8b7638b6f56ba184
- document type
- citation
- dois
- 10.1200/JCO.18.00242
- electronic publication date
- display
- 2018 Sep 13
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30212295
- immutable id
- pubmed:30212295@19092f6449f2278835b27fdb4e1147e240fa0decfc5688fc8b7638b6f56ba184
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 32
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3259-3268
- volume
- 36
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30212295
- provenance
- batch id
- 438b2803888025c6cf56
- provider
- NCBI PubMed ESummary
- record sha256
- a6c6b425a79333340e4a113d6dd1933fd72a90481428d400316aca53ab560d6c
- response sha256
- 0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
- retrieved at
- 2026-09-09T23:47:36.359220+00:00
- publication date
- display
- 2018 Nov 10
- precision
- day
- year
- 2018
- publication types
- Journal Article
- record status
- PubMed
- schema version
- 1.0
- title
- National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.
Preserved source evidence · Not medical advice